Phenylalanine

Basic Information

Item Value
DrugBank ID DB00120
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 25

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 sclerosing cholangitis KG + DL
2 congenital prothrombin deficiency KG + DL
3 epiglottitis KG + DL
4 hypophosphatemic rickets KG + DL
5 obsolete hyperuricemia (disease) KG + DL
6 laryngitis KG + DL
7 autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome KG + DL
8 brain small vessel disease 1 with or without ocular anomalies KG + DL
9 cholecystolithiasis KG + DL
10 diabetic nephropathy KG + DL
11 vitamin deficiency disorder KG + DL
12 obsolete vitamin D deficiency KG + DL
13 biotin metabolic disease KG + DL
14 familial isolated hypoparathyroidism due to impaired PTH secretion KG + DL
15 acromesomelic dysplasia, Campailla Martinelli type KG + DL
16 craniofacial conodysplasia KG + DL
17 colonic neoplasm KG + DL
18 Dahlberg-Borer-Newcomer syndrome KG + DL
19 hypouricemia, renal KG + DL
20 folic acid deficiency anemia KG + DL
21 rectosigmoid junction neoplasm KG + DL
22 renal osteodystrophy KG + DL
23 colonic lymphangioma KG + DL
24 lipoma of colon KG + DL
25 hyperphenylalaninemia due to tetrahydrobiopterin deficiency KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.